Novartis

2020 Medicine Nobel Winner Declined 2013 Prize That Overlooked His Teammates

2019 nCoV, Huanan wet market, Wuhan city, Hubei province, China, World Health Organisation, Novartis, global health emergency, Kerala, Thrissur, coronavirus, 2019 novel coronavirus, SARS, MERS, influenza, bats,

2019 Novel Coronavirus: How We Got From the First Case to Today

India’s Hetero Pulls Heart Drug From US Amid Cancer Risk Probes

What Happens When the Goals of Scientific Innovation Are Defined by Profit

Juno Shuts Down Development of High-Profile Leukaemia Drug After Deaths

India has an estimated one lakh patients with thalassaemia, a genetic disorder in which the blood cells cannot make sufficient amounts of the iron-containing pigment haeomoglobin. Credit: ssoosay/Flickr, CC BY 2.0

India’s Ignoring Its Rare Disorders and Their Orphan Drugs Led to the Thalassaemia Crisis

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. Credit: Reuters/Arnd Wiegmann/File Photo

Struggling Novartis Heart Drug Sales Boosted by New Global Medical Guidelines